Khoi Chu

1.3k total citations
22 papers, 869 citations indexed

About

Khoi Chu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Khoi Chu has authored 22 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Khoi Chu's work include Cancer Cells and Metastasis (5 papers), Bone health and treatments (4 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). Khoi Chu is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Bone health and treatments (4 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). Khoi Chu collaborates with scholars based in United States, China and Taiwan. Khoi Chu's co-authors include Fredika M. Robertson, Li‐Yuan Yu‐Lee, Sue-Hwa Lin, Christopher J. Logothetis, Yu-Chen Lee, Xiangcang Ye, Sanford H. Barsky, Ricardo Moraes, Chien-Jui Cheng and Massimo Cristofanilli and has published in prestigious journals such as Cancer Research, Developmental Cell and International Journal of Biological Macromolecules.

In The Last Decade

Khoi Chu

20 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khoi Chu United States 15 468 432 218 188 95 22 869
Gvantsa Kharaishvili Czechia 18 347 0.7× 404 0.9× 153 0.7× 221 1.2× 107 1.1× 26 776
Nikolas G. Balanis United States 12 424 0.9× 425 1.0× 232 1.1× 215 1.1× 62 0.7× 15 822
Marcela Franco Sweden 9 413 0.9× 671 1.6× 137 0.6× 402 2.1× 68 0.7× 11 1.0k
Carolina Zandueta Spain 17 305 0.7× 443 1.0× 168 0.8× 281 1.5× 54 0.6× 25 833
Akeila Bellahcène Belgium 17 536 1.1× 533 1.2× 174 0.8× 223 1.2× 58 0.6× 22 1.1k
H E Zhau United States 12 348 0.7× 568 1.3× 305 1.4× 335 1.8× 101 1.1× 16 1.0k
Ross Lake United States 15 269 0.6× 741 1.7× 229 1.1× 196 1.0× 118 1.2× 22 1.1k
Bu-Er Wang United States 10 324 0.7× 519 1.2× 440 2.0× 191 1.0× 81 0.9× 14 946
Urszula M. Polanska United Kingdom 15 432 0.9× 489 1.1× 227 1.0× 209 1.1× 93 1.0× 29 884

Countries citing papers authored by Khoi Chu

Since Specialization
Citations

This map shows the geographic impact of Khoi Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khoi Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khoi Chu more than expected).

Fields of papers citing papers by Khoi Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khoi Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khoi Chu. The network helps show where Khoi Chu may publish in the future.

Co-authorship network of co-authors of Khoi Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Khoi Chu. A scholar is included among the top collaborators of Khoi Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khoi Chu. Khoi Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Min, Khoi Chu, Qin Zhou, et al.. (2025). Dual-drug loaded hyaluronic acid conjugates coated polydopamine nanodrugs for synergistic chemo-photothermal therapy in triple negative breast cancer. International Journal of Biological Macromolecules. 308(Pt 2). 142559–142559. 4 indexed citations
2.
An, Jie, Khoi Chu, Xirong Li, et al.. (2025). Hypoxia-augmented chemotherapy potentiates imaging-guided combinatorial radionuclide-sonodynamic therapy for pancreatic cancer. Journal of Nanobiotechnology. 23(1). 539–539.
3.
An, Jie, Qin Zhou, Khoi Chu, et al.. (2025). Tumor microenvironment-responsive precise delivery nanocarrier potentiating synchronous radionuclide therapy and chemotherapy against cancer. Journal of Nanobiotechnology. 23(1). 290–290. 2 indexed citations
4.
Zhang, Yaqiong, Junping Lv, Khoi Chu, et al.. (2025). A two-emitting dye-embedded fluorescent sensor based on zirconium MOF for effective detection of fluoride. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 347. 126949–126949.
5.
Garber, Haven R., Sreyashi Basu, Sonali Jindal, et al.. (2024). Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer. Oncotarget. 15(1). 238–247. 2 indexed citations
6.
Lin, Song-Chang, Yu-Chen Lee, Guoyu Yu, et al.. (2017). Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer. Developmental Cell. 41(5). 467–480.e3. 70 indexed citations
7.
Wolfe, Adam R., Bisrat G. Debeb, Richard Larson, et al.. (2016). Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models. Oncotarget. 7(50). 82482–82492. 75 indexed citations
8.
Wolfe, Adam R., Bisrat G. Debeb, Lara Lacerda, et al.. (2015). Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a. Breast Cancer Research and Treatment. 154(3). 495–508. 51 indexed citations
9.
Robertson, Fredika M., Emanuel F. Petricoin, Steven Van Laere, et al.. (2013). Presence of anaplastic lymphoma kinase in inflammatory breast cancer. SpringerPlus. 2(1). 497–497. 40 indexed citations
10.
Fernandez, Sandra V., Fredika M. Robertson, Jianming Pei, et al.. (2013). Inflammatory breast cancer (IBC): clues for targeted therapies. Breast Cancer Research and Treatment. 140(1). 23–33. 64 indexed citations
11.
12.
Fernandez, Sandra V., Zhaomei Mu, Khoi Chu, et al.. (2012). Abstract 5342: FC-IBC-02: A new in vitro-in vivo model of inflammatory breast cancer (IBC). Cancer Research. 72(8_Supplement). 5342–5342. 2 indexed citations
13.
Ye, Xiangcang, Yu‐Chen Lee, Khoi Chu, et al.. (2011). Aberrant expression of katanin p60 in prostate cancer bone metastasis. The Prostate. 72(3). 291–300. 25 indexed citations
14.
Chu, Khoi, et al.. (2011). P4-03-06: Development and Comparative Characterization of Metastasis in Newly Developed Pre-Clinical Models of Inflammatory Breast Cancer.. Cancer Research. 71(24_Supplement). P4–3. 3 indexed citations
15.
Huang, Chih‐Fen, Khoi Chu, Mehmet Asım Bilen, et al.. (2010). Cadherin-11 Increases Migration and Invasion of Prostate Cancer Cells and Enhances their Interaction with Osteoblasts. Cancer Research. 70(11). 4580–4589. 101 indexed citations
16.
Lee, Yu‐Chen, Miao Huang, Mehmet Asım Bilen, et al.. (2010). Androgen depletion up‐regulates cadherin‐11 expression in prostate cancer. The Journal of Pathology. 221(1). 68–76. 33 indexed citations
17.
Robertson, Fredika M., Marcia A. Ogasawara, Khoi Chu, et al.. (2010). Imaging and Analysis of 3D Tumor Spheroids Enriched for a Cancer Stem Cell Phenotype. SLAS DISCOVERY. 15(7). 820–829. 50 indexed citations
18.
Chu, Khoi, et al.. (2008). Expression of the extracellular domain of OB-cadherin as an Fc fusion protein using bicistronic retroviral expression vector. Protein Expression and Purification. 61(2). 220–226. 15 indexed citations
19.
Chu, Khoi, Chien-Jui Cheng, Xiangcang Ye, et al.. (2008). Cadherin-11 Promotes the Metastasis of Prostate Cancer Cells to Bone. Molecular Cancer Research. 6(8). 1259–1267. 149 indexed citations
20.
Chen, Nanyue, Khoi Chu, Nora M. Navone, et al.. (2007). A Secreted Isoform of ErbB3 Promotes Osteonectin Expression in Bone and Enhances the Invasiveness of Prostate Cancer Cells. Cancer Research. 67(14). 6544–6548. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026